Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
Humoral Immune Responses01:36

Humoral Immune Responses

72.7K
Overview
72.7K
Antibody Actions01:26

Antibody Actions

1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Antibody Structure01:10

Antibody Structure

60.1K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.1K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

783
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
783

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

MRGPRX2 D184 engagement by food and pollen allergens: a computational hypothesis for IgE-independent mast-cell activation.

International archives of allergy and immunology·2026
Same author

A Sensor-to-Initiation Proteome Architecture Governing Regeneration Commitment in <i>Turritopsis Species</i>.

Journal of proteome research·2026
Same author

Transcriptome-Based Evaluation of Hydrogen Gas Effects for Preventing UVA-Induced Photoaging Using an Artificial Skin Model.

Geriatrics & gerontology international·2026
Same author

MRGPRX2-Mediated Mast Cell Degranulation by Monomethyl Methacrylate: Unveiling a Pathway in Bone Cement Implantation Syndrome.

Clinical and experimental pharmacology & physiology·2025
Same author

Time-sensitive effects of quercetin on rat basophilic leukemia (RBL-2H3) cell responsiveness and intracellular signaling.

PloS one·2025
Same author

Denervation-Induced Sarcopenia Model.

Methods in molecular biology (Clifton, N.J.)·2024

相关实验视频

Updated: Jul 5, 2025

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

11.8K

产生中和抗体的生产.

Erika Takemasa1, Shuang Liu2

  • 1Department of Pharmacology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.

Methods in molecular biology (Clifton, N.J.)
|January 25, 2024
PubMed
概括

本章介绍了生产单克隆抗体 (mAbs) 的混合体技术,这对于生物发育和类风湿关节炎 (RA) 研究至关重要. 它详细介绍了使用合成蛋白质体产生特定mAbs的方法,用于免疫和查.

科学领域:

  • 生物技术是生物技术.
  • 免疫学 免疫学 免疫学
  • 生物制药开发 生物制药开发

背景情况:

  • 单克隆抗体 (mAbs) 由于其特异性,同质性和可扩展性,在早期生物开发中至关重要.
  • mAbs作为工程抗体碎片和免疫调节抗体的基础材料.
  • 在基本类风湿性关节炎 (RA) 研究中,mAbs的确立实用性.

研究的目的:

  • 引入用于单克隆抗体 (mAb) 生产的基本混合体技术.
  • 概述混合瘤技术所涉及的关键步骤,从免疫到净化.
  • 要突出合成蛋白质体用于特定的膜蛋白向的应用.

主要方法:

  • 详细解释了混合瘤技术.
  • 涉及动物免疫,细胞融合和混合瘤查.
  • 使用合成蛋白质体进行增强免疫和查膜蛋白的目标.

主要成果:

  • 介绍了混合体技术作为一个可行的方法mAb生产.
  • 证明了合成蛋白质体在向特定膜蛋白的成功应用.
  • 建立了一个基础协议,用于生成高 afinity mAbs.
关键词:
细胞融合是细胞的融合.混合体瘤是一种混合体瘤.免疫接种 免疫接种单克隆抗体是一种单克隆抗体.蛋白质体蛋白质体

更多相关视频

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

8.8K
Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
12:09

Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells

Published on: November 22, 2017

18.1K

相关实验视频

Last Updated: Jul 5, 2025

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

11.8K
Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

8.8K
Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
12:09

Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells

Published on: November 22, 2017

18.1K

结论:

  • 混合体技术仍然是生物制药研究中mAb生成的基石.
  • 合成蛋白质体为实现特定抗体亲和力提供了宝贵的工具,特别是对于膜蛋白.
  • 本章提供了通过混合体技术生产mAb的全面指南.